MedTrace Logo

Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix

NCT05819515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-07-12

No results posted yet for this study

Summary

The study aims to test the non-inferiority of an Allogenic Dermal Matrix with Platelet-Rich Fibrin for treatment of gingival recessions in comparison to the Connective Tissue Graft.

Conditions

  • Gingival Recession

Interventions

PROCEDURE

Tunneled coronally advanced flap

Describes the flap design for both treatment arms

Sponsors & Collaborators

Principal Investigators

  • Hom-Lay Wang, DDS MSD PhD · University of Michigan

  • Shayan Barootchi, DMD, MS · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-29
Primary Completion
2024-03-27
Completion
2024-03-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819515 on ClinicalTrials.gov